Table 1:

Clinical Characteristics at Baseline

Baseline characteristics (N = 101)	Patients with histological healing n=56	Patients without histological healing N=45
	Median (IQR) or Percentage (n)
Age at diagnosis of CD (years)	24 (16–31)	27 (19–34)
Gender (male)	48% (n=27)	58% (n=26)
Duration of disease (years)	14 (9–25)	9 (3–19)
Disease phenotype
B1 (inflammatory)	14% (n=8)	38% (n=17)
B2 (stricturing)	61% (n=34)	40% (n=18)
B3 (penetrating)	25% (n=14)	22% (n=10)
Medications at time of colonoscopy:
Oral prednisolone/budesonide	20% (n=11)	18% (n=8)
5-amino-salcylic acid	9% (n=5)	11% (n=5)
6-mercaptopurine/azathioprine	45% (n=25)	38% (n=17)
Methotrexate	11% (n=6)	9% (n=4)
Anti-tumor necrosis factor	32% (n=18)	31% (n=14)
Ustekinumab	2% (n=1)	0% (n=0)
Vedolizumab	7% (n=4)	4% (n=2)
Endoscopic healing	73% (n=41)	51% (n=23)